杭州泰格医药科技股份有限公司关于注销部分回购股份减资的债权人通知公告
Shang Hai Zheng Quan Bao·2025-09-29 22:29

Core Viewpoint - The company, Tiger Med, has completed the cancellation of part of its repurchased shares, resulting in a reduction of its registered capital and total shares outstanding [2][3]. Group 1: Share Repurchase and Cancellation - The company approved a share repurchase plan with a total fund of no less than RMB 50 million and no more than RMB 100 million, with a maximum repurchase price of RMB 72 per share [2]. - As of April 30, 2025, the company repurchased a total of 9,806,300 shares, accounting for 1.1337% of the total share capital, with a total transaction amount of RMB 500,116,483.34 [2]. - The company has completed the cancellation of 3,922,520 shares, which is 40% of the repurchased shares, resulting in a reduction of registered capital from RMB 864,948,570 to RMB 861,026,050 [3]. Group 2: Debt Notification to Creditors - Creditors have the right to claim their debts or request guarantees within 45 days from the announcement date, with the company continuing to fulfill its obligations as per the original debt agreements [3]. - The notification specifies the process for creditors to submit their claims, including required documentation and submission methods [4][5].

Tigermed-杭州泰格医药科技股份有限公司关于注销部分回购股份减资的债权人通知公告 - Reportify